1. Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor α combination treatment of EL4-lymphoma-bearing C57BL/6 mice

   • Christian M. Krawczyk
   • Srdan Verstovšek
   • M. Jane Ehrke

   Original Article Pages: 347 - 357

2. Suppression of cytotoxic T lymphocyte activity by γ/δ T cells in tumor-bearing mice

   • Naohiro Seo
   • Kohji Egawa

   Original Article Pages: 358 - 366

3. Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies

   • Peter Ragnhammar
   • Jan Fagerberg
   • Hakan Mellstedt

   Original Article Pages: 367 - 375

4. Activation of human lymphocytes by a monoclonal antibody to B lymphoblastoid cells; molecular mass and distribution of binding protein

   • Britta Hardy
   • Michal Galli
   • Abraham Novogrodsky

   Original Article Pages: 376 - 382

5. A rat monoclonal anti-(human CD2) andL-leucine methyl ester impacts on human/SCID mouse graft and B lymphoproliferative syndrome

   • Fataki Bombil
   • Jean Pierre Kints
   • Dominique Latinne

   Original Article Pages: 383 - 389

6. CD8 T cell activation after intravenous administration of CD3×CD19 bispecific antibody in patients with non-Hodgkin lymphoma

   • Gijsbert C. de Gast
   • Inez-Anne Haagen
   • Bert J. E. G. Bast

   Original Article Pages: 390 - 396

7. Generation of cytotoxic effector cells against human melanoma

   • Stanley P. L. Leong
   • Yuan-Ming Zhou
   • Augustine Y. Lin

   Original Article Pages: 397 - 409

8. Induction of tumor-specific T lymphocyte responses in vivo by prothymosin α

   • Constantin N. Baxevanis
   • Angelos D. Gritzapis
   • Michael Papamichail

   Original Article Pages: 410 - 418